We are live on ! Find out more
INSP icon

Inspire Medical Systems
INSP

Fund managers haven’t disclosed any holdings of INSP yet.

INSP Hedge Fund Activity: Q1 2026 in Review

301 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q1 2026, worth a combined $1.8B — down 42% from $3.12B a quarter earlier.

Sellers outnumbered buyers: 91 funds closed out of INSP and 59 opened new positions — a net loss of 32 holders — while 100 trimmed existing stakes and 119 added.

The largest buyer was Deerfield Management, adding an estimated $83.8M. The largest seller was Fuller & Thaler Asset Management, exiting entirely with an estimated $61.6M sold.

  • 301 institutional investors held Inspire Medical Systems (INSP) as of Q1 2026, down from 342 in Q4 2025.
  • Funds reported $1.8B of Inspire Medical Systems stock for Q1 2026, down 42% quarter-over-quarter.
  • 59 funds opened new Inspire Medical Systems positions in Q1 2026 and 91 closed out, a net change of -32 holders.
  • The largest Inspire Medical Systems buyer in Q1 2026 was Deerfield Management, an estimated $83.8M added.
  • The largest Inspire Medical Systems seller in Q1 2026 was Fuller & Thaler Asset Management, an estimated $61.6M sold.

Based on aggregated 13F filings for Q1 2026.